A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). Export

@article{citeulike:781682, address = {SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex CM19 5AW, U.K. Peter\_J\_Lovell@sbphrd.com}, author = {Lovell, P. J. and Bromidge, S. M. and Dabbs, S. and Duckworth, D. M. and Forbes, I. T. and Jennings, A. J. and King, F. D. and Middlemiss, D. N. and Rahman, S. K. and Saunders, D. V. and Collin, L. L. and Hagan, J. J. and Riley, G. J. and Thomas, D. R.}, citeulike-article-id = {781682}, citeulike-linkout-0 = {http://view.ncbi.nlm.nih.gov/pubmed/10669560}, citeulike-linkout-1 = {http://www.hubmed.org/display.cgi?uids=10669560}, day = {10}, issn = {0022-2623}, journal = {J Med Chem}, keywords = {antagonist, sb-269970}, month = {February}, number = {3}, pages = {342--345}, posted-at = {2006-08-01 14:34:14}, priority = {2}, title = {A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970).}, url = {http://view.ncbi.nlm.nih.gov/pubmed/10669560}, volume = {43}, year = {2000} }

TY - JOUR ID - citeulike:781682 L3 - citeulike-article-id:781682 IS - 3 JF - J Med Chem SN - 0022-2623 AD - SmithKline Beecham Pharmaceuticals, New Frontiers Science Park, Harlow, Essex CM19 5AW, U.K. Peter_J_Lovell@sbphrd.com EP - 345 TI - A novel, potent, and selective 5-HT(7) antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl) phen ol (SB-269970). VL - 43 SP - 342 KW - antagonist KW - sb-269970 AU - Lovell, PJ AU - Bromidge, SM AU - Dabbs, S AU - Duckworth, DM AU - Forbes, IT AU - Jennings, AJ AU - King, FD AU - Middlemiss, DN AU - Rahman, SK AU - Saunders, DV AU - Collin, LL AU - Hagan, JJ AU - Riley, GJ AU - Thomas, DR PY - 2000/02/10/ UR - http://view.ncbi.nlm.nih.gov/pubmed/10669560 ER -